Brain drug delivery technologies: novel approaches for transporting therapeutics (Q33901037)

29 July 2017

title

Brain drug delivery technologies: novel approaches for transporting therapeutics (English)

1 reference

29 July 2017

1 reference

Jean-Michel Scherrmann

series ordinal

2

object named as

Scherrmann JM

1 reference

29 July 2017

Temsamani J

1

1 reference

29 July 2017

Rees AR

series ordinal

3

1 reference

29 July 2017

Kaczorek M

series ordinal

4

1 reference

29 July 2017

publication date

1 May 2000

1 reference

Pharmaceutical science & technology today

29 July 2017

published in

1 reference

29 July 2017

volume

3

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

155-162

1 reference

Morphology of blood-brain interfaces

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

The blood-brain barrier: morphology, molecules, and neurothelin

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Recent advances in understanding brain capillary function

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Modulation of blood-brain barrier permeability

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Drug delivery through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Lipid Solubility and Drug Penetration of the Blood Brain Barrier

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

New approaches to drug delivery through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Drug transfer across the blood-brain barrier and improvement of brain delivery

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Drug delivery to the nervous system

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Quantification and pharmacokinetics of blood-brain barrier disruption in humans

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Hyperosmolar opening of the blood-brain barrier in the energy-depleted rat brain. Part 1. Permeability studies

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Blood-brain barrier disruption for the treatment of malignant brain tumors: The National Program.

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: a light microscopic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Pharmacological blood-brain barrier modification for selective drug delivery

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Convection-enhanced delivery of macromolecules in the brain

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

A study of intrathecal, cerebrospinal fluid-to-brain exchange

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Interstitial chemotherapy with biodegradable ACNU pellet for glioblastoma

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

The therapeutic use of heroin: a review of the pharmacological literature

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Transport of [125I]transferrin through the rat blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

Trojan peptides: the penetratin system for intracellular delivery

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates

1 reference

https://api.crossref.org/works/10.1016/S1461-5347(00)00258-3

7 January 2021

10.1016/S1461-5347(00)00258-3

Identifiers

DOI

1 reference

29 July 2017

1 reference